Venture Capital Investors

Flagship Pioneering

Flagship Pioneering is a VC investing group that helps its portfolio companies by accelerating their success.

Venture Investor Overview

Venture Investor
Flagship Pioneering
Status
Active
Investor Type
Venture Capital
Activity Level
256 transactions
Funds Raised
At least $4.2 billion
Industry Focus
AgTech
Biopharmaceutical
Healthcare IT
Life Sciences

Contact Information

Contact
Noubar Afeyan
Title
Senior Managing Partner
Mailing Address
One Memorial Drive 7th Floor
Cambridge, MA 02142
USA
Phone
(617) 868-1888
Website
www.flagshippioneering.com
Email Address
Not Recorded

Background Information

Overview
Flagship Pioneering is an early-stage venture capital firm focused on creating, financing, and building innovative companies in the Life Science and Technology sectors. Headquartered in Cambridge, MA, Flagship Pioneering was founded in 1999.
Profile
Flagship Pioneering LinkedIn Company Profile
Social Media
Flagship Pioneering Company Twitter Account
Company News
Flagship Pioneering News
Facebook
Flagship Pioneering on Facebook
YouTube
Flagship Pioneering on YouTube
Last Transaction
1/30/2024

Transaction History

Our records indicate that Flagship Pioneering invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Inari
1/30/2024
$103,000,000
Quotient Therapeutics
11/22/2023
$50,000,000
Harbinger Health
9/28/2023
$140,000,000
Indigo Ag
9/18/2023
$250,000,000
Generate Biomedicines
9/15/2023
$273,000,000
Alltrna
8/9/2023
$109,000,000
Empress Therapeutics
6/21/2023
$50,000,000
Metaphore Biotechnologies
5/16/2023
$50,000,000
Ring Therapeutics
3/9/2023
$86,500,000
Ampersand Biomedicines
3/7/2023
$50,000,000
Cellarity
10/4/2022
$121,000,000
Inari
10/4/2022
$124,000,000
Senda Biosciences
8/16/2022
$123,000,000
ProFound Therapeutics
5/26/2022
$75,000,000
Tessera Therapeutics
4/19/2022
$300,000,000
Generate Biomedicines
11/22/2021
$370,000,000
Alltrna
11/10/2021
$50,000,000
YourBio Health
9/9/2021
$21,000,000
Laronde
8/31/2021
$440,000,000
Ring Therapeutics
7/29/2021
$117,000,000
Senda Biosciences
6/14/2021
$55,000,000
Inari
5/14/2021
$208,000,000
Laronde
5/11/2021
$50,000,000
Omega Therapeutics
3/31/2021
$126,000,000
Cellarity
3/1/2021
$123,000,000
Valo Health
1/19/2021
$190,000,000
Sana Biotechnology
6/29/2020
$700,000,000
Sigilon Therapeutics
3/18/2020
$80,300,000
Cygnal Therapeutics
10/9/2019
Unknown
Inari
8/7/2019
$89,000,000
KSQ Therapeutics
9/29/2018
$80,000,000
Indigo Ag
9/19/2018
$250,000,000
Kaleido Biosciences
6/26/2018
$101,000,000
Foghorn Therapeutics
3/15/2018
$50,000,000
TARIS Biomedical
12/22/2017
$25,000,000
Codiak BioSciences
11/30/2017
$76,500,000
Torque
11/15/2017
$25,000,000
Visterra
10/6/2017
$46,700,000
KSQ Therapeutics
10/3/2017
$76,000,000
Indigo Ag
9/27/2017
$156,000,000
Kaleido Biosciences
9/19/2017
$65,000,000
Evelo Biosciences
7/12/2017
$50,000,000
Rubius Therapeutics
6/22/2017
$120,000,000
Sigilon Therapeutics
6/22/2017
$23,500,000
Boragen
3/3/2017
$10,000,000
Tarveda Therapeutics
2/4/2017
$30,000,000
Incredible Foods
1/27/2017
Unknown
Seventh Sense Biosystems
11/17/2016
$10,000,000
Denali Therapeutics
3/31/2016
$9,545,000
FogHorn Systems
3/31/2016
$25,100,000
Indigo Ag
2/18/2016
$56,000,000
Tarveda Therapeutics
1/27/2016
$38,000,000
Codiak BioSciences
1/26/2016
$61,000,000
Rubius Therapeutics
12/10/2015
$25,000,000
Codiak BioSciences
11/18/2015
$31,000,000
Evelo Biosciences
11/5/2015
$35,000,000
TARIS Biomedical
10/27/2015
$32,000,000
Be Power Tech
6/30/2015
$2,500,000
Denali Therapeutics
5/15/2015
$217,000,000
Joule
5/11/2015
$40,000,000
Axcella Health
3/31/2015
$28,300,000
Red Rock Biofuels
3/18/2015
Unknown
Tarveda Therapeutics
1/7/2015
$21,000,000
Indigo Ag
11/14/2014
$7,500,000
Visterra
10/2/2014
$30,000,000
Black Duck Software
9/3/2014
$20,000,000
Seventh Sense Biosystems
8/11/2014
$16,000,000
Seres Therapeutics
6/9/2014
$10,000,000
Axcella Health
2/13/2014
$12,250,000
Novomer
12/10/2013
Unknown
Editas Medicine
11/26/2013
$43,000,000
Seres Therapeutics
11/22/2013
$10,500,000
Axcella Health
10/23/2013
$10,800,000
Joule
8/21/2013
$50,000,000
LS9
6/30/2013
Unknown
Syros Pharmaceuticals
4/12/2013
$30,000,000
TARIS Biomedical
4/2/2013
$12,500,000
BIND Therapeutics
3/31/2013
$8,698,000
WikiCell Designs
3/31/2013
$3,000,000
T2 Biosystems
3/28/2013
$40,000,000
The AeroLife
12/31/2012
$9,845,000
Tarveda Therapeutics
12/18/2012
$16,000,000
Moderna
12/6/2012
$40,000,000
TransMedics
11/21/2012
$36,150,000
Quanterix
11/15/2012
$18,500,000
WikiCell Designs
9/5/2012
$10,000,000
The AeroLife
6/30/2012
$5,000,000
Sesen Bio
5/8/2012
$20,000,000
Oasys Water
3/31/2012
$3,000,000
Advanced Electron Beams
3/31/2012
$424,000
TransMedics
3/31/2012
$2,500,000
Breathable Foods
3/31/2012
$1,999,000
Joule
1/17/2012
$70,000,000
Tarveda Therapeutics
1/9/2012
$2,800,000
Permeon Biologics
12/30/2011
$2,500,600
Acceleron Pharma
12/23/2011
$30,000,000
Agios Pharmaceuticals
11/17/2011
$78,000,000
Tangent Medical Technologies
11/3/2011
$4,500,000
T2 Biosystems
8/10/2011
$23,000,000
Avedro
7/7/2011
$25,000,000
Receptos
6/30/2011
$8,268,000
Advanced Electron Beams
6/30/2011
$2,800,000
Kovio
6/10/2011
$15,000,000
Seventh Sense Biosystems
5/11/2011
$4,500,000
TARIS Biomedical
4/13/2011
$18,300,000
Alvine Pharmaceuticals
3/31/2011
$15,060,000
Mascoma
3/31/2011
$5,000,100
Ze-Gen
3/31/2011
$8,000,000
Sesen Bio
3/31/2011
$11,000,000
Midori Renewables
3/31/2011
$3,632,000
Advanced Electron Beams
12/31/2010
$6,000,000
Novomer
12/31/2010
$4,000,000
LS9
12/20/2010
$30,000,000
Daktari Diagnostics
9/30/2010
$819,700
Ze-Gen
9/30/2010
$720,000
Avedro
8/2/2010
$4,600,000
Accuri Cytometers
7/12/2010
$6,000,000
Visterra
7/9/2010
$6,000,000
Carbon Design Systems
6/30/2010
$1,521,000
Acceleron Pharma
6/30/2010
$8,355,000
Ze-Gen
6/30/2010
$13,316,000
TetraPhase Pharmaceuticals
6/1/2010
$45,000,000
T2 Biosystems
5/25/2010
$15,000,000
Joule
4/27/2010
$30,000,000
Selecta Biosciences
4/5/2010
$15,000,000
TransMedics
3/2/2010
$35,400,000
Sesen Bio
2/17/2010
$35,000,000
Polatis
1/28/2010
$1,200,000
TARIS Biomedical
12/31/2009
$5,000,000
Acceleron Pharma
12/31/2009
$10,951,000
Receptos
11/23/2009
$25,000,000
LS9
9/25/2009
$25,000,000
Alvine Pharmaceuticals
9/15/2009
$21,500,000
Advanced Electron Beams
8/4/2009
$14,200,000
Accuri Cytometers
7/13/2009
$4,000,000
Kovio
7/13/2009
$20,000,000
TARIS Biomedical
6/24/2009
$15,000,000
Polatis
6/2/2009
$8,000,000
Carbon Design Systems
5/26/2009
$7,500,000
Avedro
5/11/2009
$10,000,000
VisEn Medical
3/31/2009
$6,000,000
Everyday Solutions
3/31/2009
$500,000
Oasys Water
2/17/2009
$10,000,000
Ze-Gen
1/13/2009
$20,000,000
Kovio
12/31/2008
$17,000,000
Maptuit
12/31/2008
$500,000
Seventh Sense Biosystems
12/16/2008
$4,180,000
T2 Biosystems
10/17/2008
$10,800,000
Novomer
9/30/2008
$3,600,000
Certus Biomedical
9/30/2008
$7,500,000
Quanterix
8/25/2008
$15,000,000
Resolvyx Pharmaceuticals
8/22/2008
$4,000,000
BG Medicine
7/17/2008
$40,000,000
Agios Pharmaceuticals
7/7/2008
$33,000,000
Selecta Biosciences
6/30/2008
$2,299,000
SiCortex
6/30/2008
$7,646,900
Mascoma
5/6/2008
$61,000,000
Concert Pharmaceuticals
4/30/2008
$37,000,000
Resolvyx Pharmaceuticals
4/22/2008
$25,000,000
VisEn Medical
4/18/2008
$5,000,000
Alvine Pharmaceuticals
3/31/2008
$11,500,000
Alinea Pharmaceuticals
3/31/2008
$2,000,000
Seahorse Bioscience
3/31/2008
$6,737,000
Netuitive
3/31/2008
$4,000,400
Arbor Networks
3/31/2008
$740,700
Pervasis Therapeutics
1/15/2008
$9,750,000
Carbon Design Systems
1/9/2008
$6,000,000
AVEO Oncology
12/31/2007
$5,499,600
Everyday Solutions
12/31/2007
$3,100,000
Polatis
12/31/2007
$5,000,000
BIND Therapeutics
11/27/2007
$16,000,000
Novomer
11/7/2007
$6,600,000
BDNA
10/31/2007
$20,000,000
Acceleron Pharma
10/30/2007
$31,000,000
Interactive Supercomputing
10/24/2007
$11,000,000
VisEn Medical
10/22/2007
$7,500,000
LS9
10/9/2007
$15,000,000
Polatis
9/30/2007
$2,500,000
Alvine Pharmaceuticals
9/30/2007
$6,500,000
Avidimer Therapeutics
9/30/2007
$2,514,000
Kovio
9/4/2007
$19,500,000
Adnexus Therapeutics
8/9/2007
$15,500,000
Ze-Gen
7/16/2007
$4,500,000
Tira Wireless
7/10/2007
$5,000,000
Ensemble Discovery
6/30/2007
$5,000,000
Polatis
6/30/2007
$1,000,000
Quanterix
6/30/2007
$4,138,000
AVEO Oncology
5/3/2007
$53,000,000
TransMedics
4/13/2007
$25,500,000
Everyday Solutions
3/31/2007
$8,150,000
Ensemble Discovery
3/31/2007
$10,000,100
LS9
3/12/2007
$5,000,000
BIND Therapeutics
2/26/2007
$2,500,000
T2 Biosystems
12/31/2006
$4,950,000
Polatis
12/31/2006
$2,500,000
Pervasis Therapeutics
12/31/2006
$5,000,000
Concert Pharmaceuticals
11/30/2006
$48,500,000
TetraPhase Pharmaceuticals
11/27/2006
$25,000,000
Mascoma
11/13/2006
$30,000,000
Morphotek
10/12/2006
$40,000,000
SiCortex
10/4/2006
$21,000,000
BG Medicine
9/30/2006
$3,550,000
Abiomed
9/30/2006
$2,000,000
Biolex
9/30/2006
$5,500,000
Carbon Design Systems
9/14/2006
$5,000,000
Alvine Pharmaceuticals
9/12/2006
$21,000,000
Acceleron Pharma
8/2/2006
$30,000,000
Mascoma
7/19/2006
$4,000,000
BlooBird Studio
6/30/2006
$1,000,000
Adnexus Therapeutics
6/26/2006
$27,000,000
Tira Wireless
3/16/2006
$13,000,000
Helicos BioSciences
3/15/2006
$40,000,000
Converged Access
1/17/2006
$8,000,000
Interactive Supercomputing
1/17/2006
$4,500,000
IntelliVid
1/17/2006
$8,000,000
Hypnion
12/19/2005
$20,100,000
Resolvyx Pharmaceuticals
12/9/2005
$17,000,000
Alinea Pharmaceuticals
10/20/2005
$45,000,000
AffinityX
10/6/2005
$3,000,000
Pervasis Therapeutics
9/30/2005
$12,000,000
INTIO
9/30/2005
$830,000
Extraprise
8/23/2005
$5,100,000
VisEn Medical
8/15/2005
$4,000,000
Ellacoya Networks
7/18/2005
$13,500,000
Ensemble Discovery
6/30/2005
$11,020,000
AVEO Oncology
6/30/2005
$5,000,100
Alere
6/30/2005
$6,750,000
IntelliVid
6/7/2005
$4,000,000
Netuitive
5/18/2005
$5,000,000
Seahorse Bioscience
3/31/2005
$10,460,000
Revivio Technology
1/18/2005
$25,000,000
Compound Therapeutics
1/18/2005
$15,500,000
Chantry Networks
10/12/2004
$17,000,000
Ellacoya Networks
9/20/2004
$7,000,000
SiCortex
9/15/2004
$21,000,000
Affinnova
8/17/2004
$4,500,000
Cellular Genomics
6/14/2004
$34,900,000
Ensemble Discovery
5/12/2004
$15,000,000
Trusted Network Technologies
4/12/2004
$12,000,000
Continuum Photonics
4/6/2004
$17,500,000
Zalicus
3/10/2004
$30,000,000
Morphotek
2/18/2004
$26,000,000
Acceleron Pharma
2/13/2004
$25,000,000
Helicos BioSciences
2/2/2004
$27,000,000
TransMedics
1/27/2004
$27,600,000
Cellular Genomics
1/21/2004
$22,300,000
Carbon Design Systems
1/13/2004
$10,000,000
Maptuit
12/16/2003
$1,000,000
Genstruct
9/9/2003
$6,500,000
Renovis
8/11/2003
$45,000,000
Revivio Technology
7/21/2003
$20,700,000
Affinnova
7/9/2003
$6,000,000
Trusted Network Technologies
6/16/2003
$6,000,000
Compound Therapeutics
5/28/2003
$12,000,000
Maptuit
4/22/2003
$8,000,000
Ellacoya Networks
1/13/2003
$14,000,000

 

Investor Contacts

Title
Name
Email & Social
Senior Managing Partner
Noubar Afeyan
  Noubar Afeyan LinkedIn Profile  Noubar Afeyan Twitter Account  Noubar Afeyan News  Noubar Afeyan on Facebook
Partner
Stephane Bancel
  Stephane Bancel LinkedIn Profile  Stephane Bancel Twitter Account  Stephane Bancel News  Stephane Bancel on Facebook
Partner
Brian Baynes
  Brian Baynes LinkedIn Profile  Brian Baynes Twitter Account  Brian Baynes News  Brian Baynes on Facebook
Partner
David Berry
  David Berry LinkedIn Profile  David Berry Twitter Account  David Berry News  David Berry on Facebook
General Partner
Douglas Cole
  Douglas Cole LinkedIn Profile  Douglas Cole Twitter Account  Douglas Cole News  Douglas Cole on Facebook
Managing Partner
Ed Kania
  Ed Kania LinkedIn Profile  Ed Kania Twitter Account  Ed Kania News  Ed Kania on Facebook
Partner
Ignacio Martinez
  Ignacio Martinez LinkedIn Profile  Ignacio Martinez Twitter Account  Ignacio Martinez News  Ignacio Martinez on Facebook
General Partner
James Matheson
  James Matheson LinkedIn Profile  James Matheson Twitter Account  James Matheson News  James Matheson on Facebook
Partner
Roger Pomerantz
  Roger Pomerantz LinkedIn Profile  Roger Pomerantz Twitter Account  Roger Pomerantz News  Roger Pomerantz on Facebook

 

Funds

Our database includes the following fund closing(s) for Flagship Pioneering. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Flagship Labs
4/2/2020
$1,100,000,000
Special Opportunities Fund II
3/20/2019
$824,000,000
Flagship Pioneering Fund VI
12/20/2017
$618,000,000
Flagship Ventures Opportunities Fund I
12/16/2016
$285,000,000
Flagship Ventures Fund V
3/26/2015
$537,000,000
Flagship Ventures Fund IV
1/11/2012
$270,000,000
Flagship Ventures Fund 2007
6/30/2007
$235,000,000
Flagship Ventures Fund 2004
8/4/2004
$150,000,000
OneLiberty Ventures 2000
1/1/2000
$201,400,000

 

Portfolio Companies

Flagship Pioneering has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Abiomed
Acceleron Pharma
Accuri Cytometers
Adnexus Therapeutics
Advanced Electron Beams
AffinityX
Affinnova
Agios Pharmaceuticals
Alere
Alinea Pharmaceuticals
Alltrna
Alvine Pharmaceuticals
Ampersand Biomedicines
Arbor Networks
Avedro
AVEO Oncology
Avidimer Therapeutics
Axcella Health
BDNA
Be Power Tech
BG Medicine
BIND Therapeutics
Biolex
Black Duck Software
BlooBird Studio
Boragen
Breathable Foods
Carbon Design Systems
Cellarity
Cellular Genomics
Certus Biomedical
Chantry Networks
Codiak BioSciences
Compound Therapeutics
Concert Pharmaceuticals
Continuum Photonics
Converged Access
Cygnal Therapeutics
Daktari Diagnostics
Denali Therapeutics
Editas Medicine
Ellacoya Networks
Empress Therapeutics
Ensemble Discovery
Evelo Biosciences
Everyday Solutions
Extraprise
FogHorn Systems
Foghorn Therapeutics
Generate Biomedicines
Genstruct
Harbinger Health
Helicos BioSciences
Hypnion
Inari
Incredible Foods
Indigo Ag
IntelliVid
Interactive Supercomputing
INTIO
Joule
Kaleido Biosciences
Kovio
KSQ Therapeutics
Laronde
LS9
Maptuit
Mascoma
Metaphore Biotechnologies
Midori Renewables
Moderna
Morphotek
Netuitive
Novomer
Oasys Water
Omega Therapeutics
Permeon Biologics
Pervasis Therapeutics
Polatis
ProFound Therapeutics
Quanterix
Quotient Therapeutics
Receptos
Red Rock Biofuels
Renovis
Resolvyx Pharmaceuticals
Revivio Technology
Ring Therapeutics
Rubius Therapeutics
Sana Biotechnology
Seahorse Bioscience
Selecta Biosciences
Senda Biosciences
Seres Therapeutics
Sesen Bio
Seventh Sense Biosystems
SiCortex
Sigilon Therapeutics
Syros Pharmaceuticals
T2 Biosystems
Tangent Medical Technologies
TARIS Biomedical
Tarveda Therapeutics
Tessera Therapeutics
TetraPhase Pharmaceuticals
The AeroLife
Tira Wireless
Torque
TransMedics
Trusted Network Technologies
Valo Health
VisEn Medical
Visterra
WikiCell Designs
YourBio Health
Zalicus
Ze-Gen

 

 

 

 

Browse more venture capital investors:

Flagship Founders | Flagstaff International

 

Share this article

 

About Our VC Investors Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.